- Home
- CRIS vs DRCT Comparison
CRIS vs DRCT Comparison
Compare CRIS & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- DRCT
- Stock Information
- Founded
- CRIS 2000
- DRCT 2018
- Country
- CRIS United States
- DRCT United States
- Employees
- CRIS N/A
- DRCT N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- DRCT Computer Software: Programming Data Processing
- Sector
- CRIS Health Care
- DRCT Technology
- Exchange
- CRIS Nasdaq
- DRCT Nasdaq
- Market Cap
- CRIS 22.9M
- DRCT 9.2M
- IPO Year
- CRIS 2000
- DRCT 2022
- Fundamental
- Price
- CRIS $1.67
- DRCT $0.40
- Analyst Decision
- CRIS Strong Buy
- DRCT Strong Buy
- Analyst Count
- CRIS 2
- DRCT 1
- Target Price
- CRIS $16.50
- DRCT $6.00
- AVG Volume (30 Days)
- CRIS 76.7K
- DRCT 224.2K
- Earning Date
- CRIS 11-13-2025
- DRCT 11-11-2025
- Dividend Yield
- CRIS N/A
- DRCT N/A
- EPS Growth
- CRIS N/A
- DRCT N/A
- EPS
- CRIS N/A
- DRCT N/A
- Revenue
- CRIS $11,405,000.00
- DRCT $36,459,000.00
- Revenue This Year
- CRIS $1.41
- DRCT $16.81
- Revenue Next Year
- CRIS $7.46
- DRCT $35.28
- P/E Ratio
- CRIS N/A
- DRCT N/A
- Revenue Growth
- CRIS 12.24
- DRCT N/A
- 52 Week Low
- CRIS $1.02
- DRCT $0.38
- 52 Week High
- CRIS $6.44
- DRCT $6.59
- Technical
- Relative Strength Index (RSI)
- CRIS 45.61
- DRCT 38.42
- Support Level
- CRIS $1.63
- DRCT $0.40
- Resistance Level
- CRIS $1.95
- DRCT $0.49
- Average True Range (ATR)
- CRIS 0.15
- DRCT 0.03
- MACD
- CRIS 0.00
- DRCT 0.00
- Stochastic Oscillator
- CRIS 17.65
- DRCT 13.33
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.